This federal contract award, with an ID of SPE2DB22D3010|SPE2DB25FP1FU, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of INGREZZA 40 MG CAPSULE 30S, a medical product. The contract has a ceiling value of $3,676.12 and a completion date of January 17, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation.
AmerisourceBergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 3/27/25, 9:55 AM